content_top
34 companies, 1 interpreter! Insight, foresight
and recommendation
and recommendation
ReNeuron Group PLC (RENE.L)
0.00
(0.00%)
content_middle
Reneuron (RENE.L) is a stem cell research company whose focus is on therapies targeting areas of poorly met medical need, including peripheral arterial disease, stroke, and retinal diseases. RENE is currently testing the effects of neural stem cells on spines for neuroregeneration, and is testing the use of fetal stem cells on stroke patients.
A UK company, used as a scientific comparable due to status of trials and disease state.
Previous Close:
0.00
Open:
1.73
Bid:
N/A
Ask:
N/A
1yr Target Price:
N/A
Day's Range:
1.69 - 1.70
52wk Range:
25.00 - 135.00
Volume:
720000
Average Daily Volume:
2885930
Market Capitalization:
0.00M
Trailing Annual Dividend Yield:
N/A
Shares Outstanding:
0.00M
content_right
- November 16, 2013 - 6:39pm | Research Notes
- August 22, 2013 - 1:53pm | Financings
- August 1, 2013 - 9:48am | Research Notes, Financings
- September 11, 2012 - 9:41am | Research Notes
- June 4, 2012 - 8:07am | Research Notes
- March 27, 2012 - 10:53am
- September 1, 2011 - 9:37am
- June 16, 2011 - 10:28am
- April 15, 2011 - 8:04am
- April 8, 2011 - 6:59am
- March 9, 2011 - 2:13pm
- January 28, 2011 - 8:00am
- July 12, 2010 - 11:39am
- March 15, 2010 - 3:41pm
- February 11, 2010 - 7:15am
- January 29, 2010 - 8:39am